Clinical Trial Update: Comparison of Insulin Aspart Produced by the NN2000 Process to the Current Process in Type 1 Diabetes [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing insulin aspart produced by the NN2000 manufacturing process with the current process in Type 1 diabetes mellitus; the study status is …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• NovoLog (insulin aspart)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 1 | Phase 3 | Status: COMPLETED